Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Explore practical strategies to avoid budget traps and keep your finances on course. You'll learn how to monitor expenses, adjust goals, and maintain consistency.
17,233 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Two decades after the Iraq War, Iran's footprint in Iraqi politics and security is shaping energy markets and investo...
Coal stocks moved higher as energy markets tensed. This piece breaks down why peabody energy other coal names jumped,...
Mortgage purchase apps holding steady in 2026 despite rising rates, underscoring persistent demand in the housing mar...
SSR Mining just sold its Copler Mine stake for $1.5 billion. This move reshapes its balance sheet, shifts portfolio r...
Nvidia is moving from data centers to the PC desk. This shift could redefine competitive dynamics among Intel, AMD, a...
As AI use grows across major tech firms, worker morale and collaboration are under strain. A close look at Anthropic’...
Start with a $1,000 investment and position it for two decades of AI-driven growth. This guide explains why Microsoft...
The World Cup has unleashed a vigorous rise in prediction markets, with activity hitting a sizable share of US sports...
A leading Substack economist warns that ghost gdp could erase friction in the economy, accelerating a white-collar re...
Two tech giants just reported blowout results. This guide breaks down what the numbers mean and how to decide which g...
Europe endures a third energy shock in four years, pressuring households and small businesses to rework budgets and s...